Search

everythinglearnresearchcommunity

for

Search:↓

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

Diagonal earlobe crease and lipoprotein(a) together help diagnose coronary heart disease.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Artificial neural networks can accurately diagnose Alopecia Areata.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Inflammation may play a role in causing androgenetic alopecia.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Both HLA-B and MICA are independently linked to alopecia areata.

Alopecia areata incognito in children can be effectively treated with triamcinolone acetonide and supplements, leading to full hair regrowth.

Etanercept may not prevent alopecia areata from coming back.

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.

A new model uses specific blood markers to predict if children's hair loss will return.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Alopecia areata in children requires thorough diagnosis and treatment due to its impact on quality of life and link to other autoimmune diseases.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.